Pay in 4 interest-free payments of $7.46 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
We're not just suppliers
AOD9604: Mechanism, Trial History & Legal Status A research overview of AOD9604's beta-3 receptor mechanism, its discontinued Phase 2b trial, cartilage research, and WADA/FDA status
Metabolic parameters including glucose tolerance, insulin sensitivity, and IGF-1 levels were monitored throughout the treatment period, confirming that the favorable metabolic profile persisted with chronic use
PMID 8133174
Administer as directed by your healthcare provider.
US$ 28.84
US$ 28.22
US$ 29.70
US$ 29.10
US$ 28.21
US$ 25.10
